We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $299M
1-Year Est. Return 53.01%
This Fund
S&P 500
This Quarter Est. Return
+21.77%
1 Year Est. Return
+53.01%
3 Year Est. Return
+109.68%
5 Year Est. Return
+113.63%
10 Year Est. Return
–
AUM
$299M
AUM Growth
+$52.9M
Cap. Flow
+$8.26M
Cap. Flow %
2.77%
Top 10 Hldgs %
65.82%
Holding
600
New
46
Increased
156
Reduced
94
Closed
36

Top Buys

Rank Stock Value
1
FHLC icon
Fidelity MSCI Health Care Index ETF
FHLC
+$18.3M
2
SIBN icon
SI-BONE Inc
SIBN
+$3.79M
3
DUOT icon
Duos Technologies
DUOT
+$2.91M
4
APGE
Apogee Therapeutics
APGE
+$2.91M
5
NPCE icon
Neuropace
NPCE
+$1.61M

Top Sells

Rank Stock Value
1
CNTA
Centessa Pharmaceuticals
CNTA
+$9.41M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$5.14M
3
ANAB icon
AnaptysBio
ANAB
+$3.29M
4
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$1.64M
5
PIPR icon
Piper Sandler
PIPR
+$1.27M

Sector Composition

Rank Sector Weight
1 Miscellaneous 64.9%
2 Healthcare 21.84%
3 Technology 4.77%
4 Financials 3.58%
5 Industrials 1.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BYND icon
551
Beyond Meat
BYND
$203M
$48 ﹤0.01%
2
– –
HRTX icon
552
Heron Therapeutics
HRTX
$65.3M
$42 ﹤0.01%
100
– –
FUBO icon
553
FuboTV Inc
FUBO
$340M
$36 ﹤0.01%
4
– –
CGC
554
Canopy Growth
CGC
$437M
$28 ﹤0.01%
30
– –
XFOR icon
555
X4 Pharmaceuticals
XFOR
$401M
$28 ﹤0.01%
6
– –
ARAY icon
556
Accuray
ARAY
$31.9M
$25 ﹤0.01%
100
– –
WW
557
WW International
WW
$180M
$15 ﹤0.01%
1
– –
AQB icon
558
AquaBounty Technologies
AQB
$5.92M
$10 ﹤0.01%
10
– –
ICU icon
559
SeaStar Medical
ICU
$13.1M
$7 ﹤0.01%
2
– –
PTEN icon
560
Patterson-UTI
PTEN
$4.74B
$6 ﹤0.01%
1
– –
GNPX icon
561
Genprex
GNPX
$2.87M
– –
0
– –
ABVX
562
Abivax
ABVX
$10B
– –
-150
Closed -$16.7K
ALC icon
563
Alcon
ALC
$34.1B
– –
-40
Closed -$3.02K
APYX icon
564
Apyx Medical
APYX
$128M
– –
-5,000
Closed -$18.4K
BJ icon
565
BJs Wholesale Club
BJ
$11.8B
– –
-63
Closed -$6.2K
CBOE icon
566
Cboe Global Markets
CBOE
$31.2B
– –
-35
Closed -$9.84K
CDNA icon
567
CareDx
CDNA
$2.63B
– –
-475
Closed -$8.25K
CMS icon
568
CMS Energy
CMS
$21.5B
– –
-63
Closed -$4.89K
CNTA
569
DELISTED
Centessa Pharmaceuticals
CNTA
– –
-236,785
Closed -$9.41M
COF icon
570
Capital One
COF
$135B
– –
-20
Closed -$3.65K
CVE icon
571
Cenovus Energy
CVE
$59.7B
– –
-45
Closed -$1.19K
DT icon
572
Dynatrace
DT
$15B
– –
-133
Closed -$4.92K
GLOB icon
573
Globant
GLOB
$1.69B
– –
-547
Closed -$25.2K
HII icon
574
Huntington Ingalls Industries
HII
$11.3B
– –
-15
Closed -$5.7K
HOOD icon
575
Robinhood
HOOD
$110B
– –
-75
Closed -$5.2K
20 21 22
23
24

Similar funds

GWM
Glass Wealth Management San Antonio, Texas $299M AUM 66.9% 1-Year Est. Return
HP
Highlander Partners Dallas, Texas $298M AUM 53.88% 1-Year Est. Return
SFS
Searcy Financial Services Overland Park, Kansas $298M AUM 20.59% 1-Year Est. Return
SIA
Schear Investment Advisers Cincinnati, Ohio $299M AUM 90.52% 1-Year Est. Return
MWM
Maltin Wealth Management Ridgewood, New Jersey $299M AUM 22.87% 1-Year Est. Return
WFA
Woodward Financial Advisors Chapel Hill, North Carolina $299M AUM
SC
Sawyer & Company Boston, Massachusetts $298M AUM 31.71% 1-Year Est. Return
KWA
Kondo Wealth Advisors Pasadena, California $299M AUM 21.97% 1-Year Est. Return

HighMark Wealth Management's Q2 2026 Portfolio in Review

As of Q2 2026, HighMark Wealth Management held 600 positions worth $299M, up 22% from $246M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

HighMark Wealth Management's Q2 2026 filing shows 46 new, 156 increased, 94 reduced and 36 closed positions. Its largest new stake was Duos Technologies: 289,884 shares worth $3.48M. The largest sale was Centessa Pharmaceuticals, an estimated $9.41M.

By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, down from 65% a quarter earlier, followed by Healthcare and Technology.

  • HighMark Wealth Management's largest Q2 2026 buy was Duos Technologies: 289,884 shares worth $3.48M.
  • HighMark Wealth Management added most to Fidelity MSCI Health Care Index ETF in Q2 2026, an estimated $18.3M increase.
  • HighMark Wealth Management's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $5.14M.
  • HighMark Wealth Management fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $9.41M.
  • HighMark Wealth Management's ten largest holdings make up 66% of its $299M portfolio in Q2 2026.
  • HighMark Wealth Management opened 46 new positions and closed 36 in Q2 2026.
  • HighMark Wealth Management's portfolio value rose 22% quarter-over-quarter to $299M.

Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.